Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women.

However, the expert panel noted that survival benefits usually are not noted until 5 to 10 years after diagnosis, which makes such a treatment of marginal or no benefit in those with life expectancies lesser than 5 years.[ 15 ] The Early Breast Cancer Trialists' Collaborative Group (EBCTCG) published an updated analysis using individual patient data from 10,801 patients included in 17 randomized trials of radiation after breast-conserving surgery.[ 16 ] This publication revealed that the addition of radiation therapy was associated with a highly significant absolute benefit of 15.7% in any first recurrence (local, regional, or distant recurrence) at 10 years.

also in 132,142 other papers